Brief: Quantum Genomics Presents Results On NEW-HOPE And QUORUM

Quantum Genomics SA

31/01/2019 18:10

Jan 31 (Reuters) - QUANTUM GENOMICS SA  ALQGC.PA :
    * PIVOTAL PHASE III STUDY IN RESISTANT HYPERTENSION - NEW
HOPE
STUDY
    * NEW-HOPE STUDY DEMONSTRATED HIGHLY SIGNIFICANT
ANTI-HYPERTENSIVE
EFFECT OF FIRIBASTAT
    * IS LAUNCHING QUORUM, A PHASE IIB STUDY TO EVALUATE
EFFICACY AND
SAFETY OF FIRIBASTAT COMPARED TO RAMIPRIL IN HEART FAILURE
PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION (AMI)
    * FIRST PATIENTS OF QUORUM  WILL BE INCLUDED AT BEGINNING OF
Q2 OF
2019.

Source text for Eikon:  ID:nACT56968 
Further company coverage:  ALQGC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))